Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline

R. K. Ramanathan, R. L. Korn, E. G. Chiorean, H. Liu, D. D. Von Hoff

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline'. Together they form a unique fingerprint.